Continuous infusion of recombinant factor VIIa: continue or not?
Ewenstein, B.M.
Thrombosis and Haemostasis 86(4): 942-944
2001
ISSN/ISBN: 0340-6245 PMID: 11686349 Document Number: 531143
Document emailed within 1 workday
Related Documents
Pruthi, R.K.; Mathew, P.; Valentino, L.A.; Sumner, M.J.; Seremetis, S.; Hoots, W.K. 2007: Haemostatic efficacy and safety of bolus and continuous infusion of recombinant factor VIIa are comparable in haemophilia patients with inhibitors undergoing major surgery. Results from an open-label, randomized, multicenter trial Thrombosis and Haemostasis 98(4): 726-732Kam, C.M.; Vlasuk, G.P.; Smith, D.E.; Arcuri, K.E.; Powers, J.C. 1990: Thioester chromogenic substrates for human factor VIIa: substituted isocoumarins are inhibitors of factor VIIa and in vitro anticoagulants Thrombosis and Haemostasis 64(1): 133-137
Nicolaisen, E.M.; Hansen, L.L.; Poulsen, F.; Glazer, S.; Hedner, U. 1996: Immunological aspects of recombinant factor VIIa (rFVIIa) in clinical use Thrombosis and Haemostasis 76(2): 200-204
Hamaekers, A.E.W.; van Mook, W.N.K.A.; Offermans, J.P.M.; Marcus, M.A.E. 2006: Successful use of recombinant factor VIIa for treatment of severe postpartum hemorrhage American Journal of Critical Care: An Official Publication American Association of Critical-Care Nurses 15(4): 399-401
Smaradottir, A.; Bona, R. 2004: A case of acquired von Willebrand syndrome successfully treated with recombinant Factor VIIa during thyroidectomy Thrombosis and Haemostasis 92(3): 666-667
Shamsi, T.Sultan.; Hossain, N.; Soomro, N.; Hasan, J.Ara.; Noorani, M.; Kazi, S.; Quraishy, M.Saeed.; Jameel, B.; Sultan, S.Tipu.; Haider, S. 2005: Use of recombinant factor VIIa for massive postpartum haemhorrage: case series and review of literature Jpma. Journal of the Pakistan Medical Association 55(11): 512-515
Lazarev, A.F.; Rossokha, A.V.; Mamaev, A.N.; Khodorenko, S.A.; Mamaeva, I.V.; Nazarov, A.V.; Tsyvkina, L.P. 2012: Use of recombinant factor VIIa to reduce transfusional load in hemorrhaging patients after surgery for malignant tumors Voprosy Onkologii 58(4): 568-571
Morgan, J.M.; Piraino, A.J.; Saris, S.D.; Capuzzi, D.M. 1994: Pharmacodynamics of a continuous intravenous infusion of CGP-35126 recombinant human insulin-like growth factor-I (rhIGF-I) on glucose and insulin levels in healthy males International Journal of Clinical Pharmacology and Therapeutics 32(5): 235-239
Tanchev, S.; Platikanov, V.; Markova, S.; Slavov, N.; Bogdanova, A.; Dimitrova, D. 2004: Use of recombinant factor VIIa for the control of massive bleeding caused by uterine hypotonia in post-placental period Akusherstvo i Ginekologiia 43(1): 16-20
Brown, C.V.R.; Sowery, L.; Curry, E.; Valadka, A.B.; Glover, C.S.; Grabarkewitz, K.; Green, T.; Hail, S.; Admire, J. 2012: Recombinant factor VIIa to correct coagulopathy in patients with traumatic brain injury presenting to outlying facilities before transfer to the regional trauma center American Surgeon 78(1): 57-60
Da Pozzo, L.F.; Hough, K.L.; Holder, W.D. 1992: Toxicity and immunologic effects of continuous infusion of recombinant human interleukin-2 administered by selective hepatic perfusion in dogs Surgery 111(3): 326-334
Contino, P.B.; Andree, H.A.; Nemerson, Y. 1994: Flow dependence of factor X activation by tissue factor-factor VIIa Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 45(1): 81-90
Velotti, F.; Tubaro, A.; Stoppacciaro, A.; Pettinato, A.; Morrone, S.; Bossola, P.; Napolitano, T.; Miano, L.; Ruco, L.; Piccoli, M. 1990: Local/regional recombinant interleukin 2 (rIL-2) immunotherapy of tumors. Intra-arterial continuous infusion of rIL-2 in bladder cancer patients: a phase i study Annali Dell'istituto Superiore di Sanita 26(3-4): 411-421
Almus, F.E.; Rao, L.V.; Rapaport, S.I. 1989: Functional properties of factor VIIa/tissue factor formed with purified tissue factor and with tissue factor expressed on cultured endothelial cells Thrombosis and Haemostasis 62(4): 1067-1073
Manco-Johnson, M.J. 1996: Family issues in continuous infusion therapy with factor VIII Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 7(Suppl): S21-S25
Mitsuhata, H.; Matsumoto, S.; Hasegawa, J.; Ohtaka, K. 1991: Continuous intravenous pethidine infusion for analgesia after upper abdominal surgery: a randomized, prospective double-blind comparison with continuous epidural infusion of pethidine Masui. Japanese Journal of Anesthesiology 40(12): 1770-1776
Lopez-Vilchez, I.; Escolar, G.; Diaz-Ricart, M.; Fuste, B.; Galan, A.M.; White, J.G. 2007: Tissue factor-enriched vesicles are taken up by platelets and induce platelet aggregation in the presence of factor VIIa Thrombosis and Haemostasis 97(2): 202-211
Itano, S.; Hirai, K.; Kajiwara, M.; Ijuin, H.; Yoshiyama, Y.; Yoshida, T.; Sakata, K.; Ono, N.; Noguchi, H.; Sakai, T. 1994: A study of the drug distribution on intra-hepatic arterial infusion chemotherapy; how much difference between continuous infusion and rapid infusion? Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(13): 2136-2139
Lindhout, T.; Franssen, J.; Willems, G. 1995: Kinetics of the inhibition of tissue factor-factor VIIa by tissue factor pathway inhibitor Thrombosis and Haemostasis 74(3): 910-915
Sica, S.; Di Mario, A.; Salutari, P.; Rutella, S.; Chiusolo, P.; Rumi, C.; Menichella, G.; D'Onofrio, G.; Leone, G. 1995: Chemotherapy and recombinant human granulocyte colony-stimulating factor primed donor leukocyte infusion for treatment of relapse after allogeneic bone marrow transplantation Bone Marrow Transplantation 16(3): 483-485